Niraparib Suppliers & Bulk Manufacturers

Available Forms: Capsule/ Tablet

Available Strengths: 100 mg, 200 mg, 300 mg

Reference Brands: Zejula (USA/EU)

Category: Oncology Cancer Care

Niraparib is an oral PARP inhibitor used for the treatment and maintenance of advanced ovarian, fallopian tube, or primary peritoneal cancer. It works by blocking the PARP enzyme, which helps repair DNA damage in cancer cells, leading to cell death, especially in tumors with BRCA mutations or homologous recombination deficiency (HRD). Niraparib is available in capsules or tablets and is taken once daily, with the dose adjusted based on body weight and platelet count. It helps delay cancer progression and is generally used after platinum-based chemotherapy. Niraparib is available in Capsule/ Tablet and strengths such as 100 mg, 200 mg, 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Niraparib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Niraparib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.